ASA Gold and Precious Metals Stock Price, News & Analysis

ASA Gold and Precious Metals Limited (NYSE: ASA) announced significant changes to its Board of Directors. Directors William Donovan and Mary Joan Hoene have resigned from their positions, with Hoene stepping down as Board Chair after serving since 2019. The company has appointed Karen Caldwell as a new Director until the 2025 Annual General Meeting of Shareholders.

Caldwell, 66, brings extensive financial leadership experience as the current CFO of Tides Organization and previous CFO roles at Reform Alliance, NHP Foundation, and New York City Housing Authority. She will serve as Chair of the Audit and Ethics Committee and has been designated as an "audit committee financial expert."

Saba Capital Management, L.P., holding a 17.2% stake in ASA Gold and Precious Metals Limited (NYSE: ASA), announced the final certified voting results from the Fund's Special Meeting held on June 13, 2025. Shareholders approved expanding the Board of Directors to five members and elected independent governance expert Maryann Bruce as the fifth director. The newly constituted five-member Board, comprising Maryann Bruce, Ketu Desai, William Donovan, Mary Joan Hoene, and Paul Kazarian, will serve until the 2025 Annual Meeting of Shareholders, when shareholders will vote on the entire Board composition.

ASA Gold and Precious Metals Limited (NYSE: ASA) shareholders have voted to expand the Board of Directors to five members and elected Maryann Bruce as an independent director at the Special Meeting held on June 13, 2025. The vote was led by Saba Capital Management, the Fund's largest shareholder with a 17.2% stake. The new five-member Board will include Maryann Bruce, Ketu Desai, William Donovan, Mary Joan Hoene, and Paul Kazarian, serving until the 2025 Annual Meeting. Boaz Weinstein, Founder and CIO of Saba, expressed gratitude for shareholder support and highlighted Bruce's extensive fund management background and governance expertise as valuable additions to the Fund.

The Supreme Court of Bermuda has extended an interim injunction against ASA Gold and Precious Metals Limited (NYSE: ASA) and two of its directors, Mary Joan Hoene and William Donovan, prohibiting them from using company resources to interfere with the upcoming June 13th Special Meeting and 2025 Annual General Meeting. The court ruled that the Litigation Committee, involving Hoene and Donovan, likely lacked authority to solicit proxies opposing shareholder resolutions. Board member Paul Kazarian, who sought the injunction, criticized Hoene and Donovan for allegedly spending millions in company resources to oppose shareholder interests. The court found there is "a serious issue to be tried" regarding the Litigation Committee's authority and noted the potential exclusion of Kazarian's rights as a director in a deadlocked Board situation.

The Supreme Court of Bermuda has issued an interim injunction against ASA Gold and Precious Metals Limited (NYSE: ASA) and two of its directors, Mary Joan Hoene and William Donovan, following legal action by board member Paul Kazarian. The injunction, issued on May 8, 2025, restrains the defendants from interfering with upcoming shareholder meetings and requires withdrawal of recent SEC filings. The court found Kazarian's claims "seriously arguable" with "a realistic prospect of success." This follows a March 28, 2025 ruling by the U.S. District Court that found the defendants violated federal law by adopting an illegal poison pill against the Investment Company Act of 1940. Despite this ruling, Hoene and Donovan extended the poison pill through their board committee on March 31, 2025.

Saba Capital Management, ASA Gold and Precious Metals 's (NYSE: ASA) largest shareholder with 17.2% ownership, has filed a lawsuit against ASA and its legacy Board members over an unlawful poison pill. The lawsuit follows the Court's March 28th ruling that declared ASA's previous shareholder rights plan violated the Investment Company Act of 1940.

The controversial poison pill has been in effect for over 474 days, preventing Saba from purchasing additional shares. After the Court's ruling, ASA quickly readopted a substantively identical pill, prompting further legal action. The dispute highlights ongoing governance issues, including the formation of 'Shadow Board' committees that excluded newly elected directors from critical decisions.

Saba seeks recission of the newly adopted poison pill, a declaration of its violation of federal law, and an injunction against further implementation. The firm argues that ASA's actions prioritize fees and self-preservation over shareholder interests.

Saba Capital Management, ASA Gold and Precious Metals 's (NYSE: ASA) largest shareholder, has filed a motion with the U.S. District Court for the Southern District of New York to invalidate ASA's latest poison pill issued on March 31, 2025.

This follows the Court's March 28, 2025 ruling that ASA's previous poison pill violated the Investment Company Act of 1940. The Court found that ASA and directors William Donovan, Bruce Hanson, Mary Joan Hoene, and Axel Merk broke federal law, citing entrenchment as a plausible motivation.

Despite the Court's decision to rescind the poison pill, ASA issued an extension the next business day. Saba's founder Boaz Weinstein is calling for the directors to return millions in shareholder capital spent defending the poison pill and their board compensation from the past two years.

ASA Gold and Precious Metals (NYSE: ASA) has adopted a -duration shareholder rights plan through July 29, 2025, in response to Saba Capital Management's efforts to gain board control. The plan was implemented after Saba, holding approximately 17.18% of ASA's shares, placed two directors on the board and seeks further control without presenting clear plans for the company's future.

The Rights Plan grants shareholders one right per common share as of April 9, 2025, becoming exercisable if any entity acquires 15% or more of ASA's shares. Current holders above 15% are grandfathered but cannot acquire additional 0.25% or more shares without triggering the plan. If triggered, shareholders can purchase additional shares at $1.00 per share or exchange rights for common shares.

The company recently implemented shareholder-friendly initiatives, including a stock repurchase plan and doubling the distribution rate to $0.04 per share during fiscal year 2024.

ASA Gold and Precious Metals (NYSE: ASA) faces a legal setback as the United States District Court for the Southern District of New York ruled against the company's December 2024 shareholder rights plan. The court's March 28, 2025 judgment determined that the rights plan violated the Investment Company Act of 1940's requirement for rights plans to expire within 120 days of issuance.

The December 2024 Rights Plan has been deemed rescinded and is no longer in effect. Previously adopted rights plans had already expired according to their terms. The case, Saba Capital Master Fund, v. ASA Gold and Precious Metals (No. 24-CV-690), will be appealed by the company's Litigation Committee.